Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Current Assets (2022 - 2025)

Historic Current Assets for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $8.6 million.

  • bioAffinity Technologies' Current Assets rose 23790.27% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year increase of 23790.27%. This contributed to the annual value of $2.7 million for FY2024, which is 3216.03% down from last year.
  • As of Q3 2025, bioAffinity Technologies' Current Assets stood at $8.6 million, which was up 23790.27% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Current Assets ranged from a high of $14.1 million in Q3 2022 and a low of $1.7 million during Q2 2025
  • Over the past 4 years, bioAffinity Technologies' median Current Assets value was $4.0 million (recorded in 2023), while the average stood at $6.1 million.
  • Per our database at Business Quant, bioAffinity Technologies' Current Assets tumbled by 6904.53% in 2024 and then surged by 23790.27% in 2025.
  • Quarter analysis of 4 years shows bioAffinity Technologies' Current Assets stood at $12.0 million in 2022, then tumbled by 66.79% to $4.0 million in 2023, then plummeted by 32.16% to $2.7 million in 2024, then surged by 219.6% to $8.6 million in 2025.
  • Its Current Assets stands at $8.6 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.9 million for Q1 2025.